REnal Function in Liver Transplantation: Everolimus With Calcineurin Inhibitor (CNI)-Sparing sTrategy
Clinical trial NCT02115113 · COMPLETED
Trial details
- NCT number
- NCT02115113
- Sponsor
- Novartis Pharmaceuticals
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2014-03-28
- Primary completion
- 2016-09-30
- Enrollment
- 78
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.